3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Lymphoid
1
Conditions
Pancreatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Extranodal NK-T-Cell
2
Thoracic Neoplasms
1
Squamous Non-small-cell Lung Cancer
1
Oligospermia
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Lymphohistiocytosis, Hemophagocytic
1
Lung Neoplasms
1
Lung Diseases
1
Fibrosis
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Biliary Tract Neoplasms
1
Adenocarcinoma Pancreas
1
Adenocarcinoma
1
Interventions
zanubrutinib
1
ruxolitinib
1
pegaspargase
1
Rituximab
1
Gemcitabine
1
Etoposide
1
Dexamethasone
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphohistiocytosis, Hemophagocytic
×
Gemcitabine
×
Clear all
NCT04999878
2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4
Unknown
30 enrolled